Accelerated Technologies Partners

Note: Browser Cookies
must be enabled for
successful authentication.

Accelerated Technologies Partners (“ATP”) is an investment partnership that focuses on medical devices and actively leverages a structured collaboration between world-leading physicians, experienced operational management and dedicated capital to produce superior returns and substantial clinical value. By aligning the interests and harnessing the collective resources of physicians, management and investors from inception through exit, the ATP strategy supports the acceleration of product development and lowers market and execution risks, enhancing capital efficiency and improving the likelihood of outstanding returns.

ATP MISSION

ALIGN the interests of physicians, investors and management to accelerate the development of a portfolio of important new medical devices.

ANALYZE unmet clinical needs in conjunction with leading physicians to identify high value opportunities for innovation to significantly improve existing treatment paradigms.

INNOVATE by creating or sourcing the optimal solution to address a targeted unfulfilled clinical need.

REALIZE exceptional investor returns and meaningful clinical impact through superior execution that leverages the collective knowledge and resources of a comprehensive team of experts.

Continental Plaza, 401 Hackensack Avenue, 9th floor | Hackensack, NJ 07601 | tel: 201.487.1005 | fax: 201.487.2005 | info@atpfunds.com